• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质递药系统的体外消化试验:钙离子与富含甘油三酯的脂质溶液中释放的脂肪酸结合形成皂,降低胶体消化产物的溶解能力。

In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products.

机构信息

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Melbourne, Victoria, Australia.

出版信息

Int J Pharm. 2013 Jan 30;441(1-2):323-33. doi: 10.1016/j.ijpharm.2012.11.024. Epub 2012 Nov 23.

DOI:10.1016/j.ijpharm.2012.11.024
PMID:23178598
Abstract

In vitro digestion testing is of practical importance to predict the fate of drugs administered in lipid-based delivery systems. Calcium ions are often added to digestion media to increase the extent of digestion of long-chain triglycerides (LCTs), but the effects they have on phase behaviour of the products of digestion, and consequent drug solubilization, are not well understood. This study investigates the effect of calcium and bile salt concentrations on the rate and extent of in vitro digestion of soybean oil, as well as the solubilizing capacity of the digestion products for two poorly water-soluble drugs, fenofibrate and danazol. In the presence of higher concentrations of calcium ions, the solubilization capacities of the digests were reduced for both drugs. This effect is attributed to the formation of insoluble calcium soaps, visible as precipitates during the digestions. This reduces the availability of liberated fatty acids to form mixed micelles and vesicles, thereby reducing drug solubilization. The use of high calcium concentrations does indeed force in vitro digestion of LCTs but may overestimate the extent of drug precipitation that occurs within the intestinal lumen.

摘要

体外消化试验对于预测脂质给药系统中药物的命运具有实际意义。为了增加长链甘油三酯(LCT)消化的程度,通常会向消化介质中添加钙离子,但人们对其对消化产物的相行为以及随之而来的药物增溶作用的影响还了解甚少。本研究考察了钙离子和胆汁盐浓度对大豆油体外消化速率和程度的影响,以及消化产物对两种疏水性差的药物非诺贝特和丹那唑的增溶能力。在存在较高浓度的钙离子的情况下,两种药物的消化物的增溶能力都降低了。这种效应归因于形成不溶性的钙皂,在消化过程中可见为沉淀物。这减少了游离脂肪酸形成混合胶束和囊泡的可用性,从而降低了药物的增溶作用。使用高浓度的钙离子确实可以强制进行 LCT 的体外消化,但可能会高估肠腔中发生的药物沉淀的程度。

相似文献

1
In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products.脂质递药系统的体外消化试验:钙离子与富含甘油三酯的脂质溶液中释放的脂肪酸结合形成皂,降低胶体消化产物的溶解能力。
Int J Pharm. 2013 Jan 30;441(1-2):323-33. doi: 10.1016/j.ijpharm.2012.11.024. Epub 2012 Nov 23.
2
Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.为了建立标准化的基于脂质的制剂的体外测试方法。2. 胆汁盐浓度和药物载药量对 I 型、II 型、IIIA 型、IIIB 型和 IV 型制剂在体外消化过程中的性能的影响。
Mol Pharm. 2012 Nov 5;9(11):3286-300. doi: 10.1021/mp300331z. Epub 2012 Oct 22.
3
In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.采用分散和消化试验对无药物和非诺贝特载脂体制剂进行体外评估,可深入了解制剂在肠道中的可能命运。
Eur J Pharm Sci. 2013 Jul 16;49(4):748-60. doi: 10.1016/j.ejps.2013.04.036. Epub 2013 May 16.
4
The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.对于碱性药物,在基于脂质的制剂肠道处理过程中药物过饱和的可能性可能会增加。
Mol Pharm. 2013 Jul 1;10(7):2601-15. doi: 10.1021/mp400035z. Epub 2013 Jun 10.
5
Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.设计用于口服给药的脂基制剂:对消化的影响
AAPS PharmSciTech. 2012 Jun;13(2):637-46. doi: 10.1208/s12249-012-9787-2. Epub 2012 May 1.
6
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.常见制剂脂质消化产生的胶体相的分离与表征及其对选定难溶性药物表观溶解度影响的评估。
J Pharm Sci. 2003 Mar;92(3):634-48. doi: 10.1002/jps.10329.
7
Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.难溶性药物在甘油三酯脂质中混悬液制剂的体外消化过程中的药物增溶行为。
Pharm Res. 2004 Feb;21(2):254-60. doi: 10.1023/b:pham.0000016283.87709.a9.
8
Choice of nonionic surfactant used to formulate type IIIA self-emulsifying drug delivery systems and the physicochemical properties of the drug have a pronounced influence on the degree of drug supersaturation that develops during in vitro digestion.用于制备IIIA型自乳化药物递送系统的非离子表面活性剂的选择以及药物的物理化学性质,对体外消化过程中产生的药物过饱和度程度有显著影响。
J Pharm Sci. 2014 Apr;103(4):1050-63. doi: 10.1002/jps.23856. Epub 2014 Jan 27.
9
Using the polymer partitioning method to probe the thermodynamic activity of poorly water-soluble drugs solubilized in model lipid digestion products.采用聚合物分配法探究溶解于模型脂质消化产物中的难溶性药物的热力学活性。
J Pharm Sci. 2003 Jun;92(6):1262-71. doi: 10.1002/jps.10390.
10
Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity.模拟进食状态下肠道液的生物相关介质:胶体相特征及对增溶能力的影响。
J Pharm Sci. 2010 Aug;99(8):3522-32. doi: 10.1002/jps.22122.

引用本文的文献

1
Roles of different polysaccharides on the structures of alginate-based Bigel beads and co-delivery of bioactives.不同多糖对海藻酸盐基双凝胶珠结构及生物活性物质共递送的作用。
Food Chem X. 2025 Mar 10;27:102359. doi: 10.1016/j.fochx.2025.102359. eCollection 2025 Apr.
2
The lipid digestion behavior of oil-in-water emulsions stabilized by different particle-sized insoluble dietary fiber from citrus peel.由不同粒径的柑橘皮不溶性膳食纤维稳定的水包油乳液的脂质消化行为。
Food Chem X. 2023 Aug 9;19:100831. doi: 10.1016/j.fochx.2023.100831. eCollection 2023 Oct 30.
3
Development and Pharmacokinetic Evaluation of Novasomes for the Trans-nasal Delivery of Fluvoxamine Using Arachidonic Acid-Carboxymethyl Chitosan Conjugate.
使用花生四烯酸-羧甲基壳聚糖缀合物的新型脂质体用于氟伏沙明经鼻递送的研发及药代动力学评价
Pharmaceutics. 2023 Aug 31;15(9):2259. doi: 10.3390/pharmaceutics15092259.
4
Supersaturation and Solubilization upon In Vitro Digestion of Fenofibrate Type I Lipid Formulations: Effect of Droplet Size, Surfactant Concentration and Lipid Type.非诺贝特 I 型脂质制剂体外消化时的过饱和与增溶作用:液滴大小、表面活性剂浓度和脂质类型的影响
Pharmaceutics. 2021 Aug 18;13(8):1287. doi: 10.3390/pharmaceutics13081287.
5
Use of Oleogels to Replace Margarine in Steamed and Baked Buns.使用油凝胶替代馒头和面包中的人造黄油。
Foods. 2021 Jul 31;10(8):1781. doi: 10.3390/foods10081781.
6
Reducing Intestinal Digestion and Absorption of Fat Using a Nature-Derived Biopolymer: Interference of Triglyceride Hydrolysis by Nanocellulose.利用天然生物聚合物减少脂肪的肠道消化和吸收:纳米纤维素对甘油三酯水解的干扰。
ACS Nano. 2018 Jul 24;12(7):6469-6479. doi: 10.1021/acsnano.8b03074. Epub 2018 Jun 12.
7
Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.胃中的脂质——对食物影响口服药物吸收评估的启示。
Pharm Res. 2018 Feb 8;35(3):55. doi: 10.1007/s11095-017-2289-x.
8
The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.难溶性药物的沉淀行为,重点在于脂质体制剂的溶出
Pharm Res. 2016 Mar;33(3):548-62. doi: 10.1007/s11095-015-1829-5. Epub 2015 Nov 23.
9
Mechanism of enhanced antiosteoporosis effect of circinal-icaritin by self-assembled nanomicelles in vivo with suet oil and sodium deoxycholate.环阿尔卡亭通过与牛油和脱氧胆酸钠自组装纳米胶束在体内增强抗骨质疏松作用的机制。
Int J Nanomedicine. 2015 Mar 25;10:2377-89. doi: 10.2147/IJN.S76191. eCollection 2015.
10
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels.迈向基于脂质制剂的标准化体外试验的建立,第6部分:不同胰酶和钙水平的影响。
AAPS J. 2014 Nov;16(6):1344-57. doi: 10.1208/s12248-014-9672-x. Epub 2014 Oct 2.